Trial of an Intervention to Improve Acute Heart Failure Outcomes

医学 危险系数 心力衰竭 随机对照试验 置信区间 急诊医学 累积发病率 入射(几何) 儿科 重症监护医学 内科学 移植 光学 物理
作者
Douglas S. Lee,Sharon E. Straus,Michael E. Farkouh,Peter C. Austin,Monica Taljaard,Alice Chong,Christine Fahim,Stephanie Poon,Peter Cram,Stuart Smith,Robert S. McKelvie,Liane Porepa,Michael Hartleib,Peter R. Mitoff,Robert M. Iwanochko,Arlene MacDougall,Steven Shadowitz,Howard Abrams,Esam Elbarasi,Jiming Fang,Jacob A. Udell,Michael J. Schull,Susanna Mak,Heather J. Ross
出处
期刊:The New England Journal of Medicine [New England Journal of Medicine]
卷期号:388 (1): 22-32 被引量:73
标识
DOI:10.1056/nejmoa2211680
摘要

Patients with acute heart failure are frequently or systematically hospitalized, often because the risk of adverse events is uncertain and the options for rapid follow-up are inadequate. Whether the use of a strategy to support clinicians in making decisions about discharging or admitting patients, coupled with rapid follow-up in an outpatient clinic, would affect outcomes remains uncertain.In a stepped-wedge, cluster-randomized trial conducted in Ontario, Canada, we randomly assigned 10 hospitals to staggered start dates for one-way crossover from the control phase (usual care) to the intervention phase, which involved the use of a point-of-care algorithm to stratify patients with acute heart failure according to the risk of death. During the intervention phase, low-risk patients were discharged early (in ≤3 days) and received standardized outpatient care, and high-risk patients were admitted to the hospital. The coprimary outcomes were a composite of death from any cause or hospitalization for cardiovascular causes within 30 days after presentation and the composite outcome within 20 months.A total of 5452 patients were enrolled in the trial (2972 during the control phase and 2480 during the intervention phase). Within 30 days, death from any cause or hospitalization for cardiovascular causes occurred in 301 patients (12.1%) who were enrolled during the intervention phase and in 430 patients (14.5%) who were enrolled during the control phase (adjusted hazard ratio, 0.88; 95% confidence interval [CI], 0.78 to 0.99; P = 0.04). Within 20 months, the cumulative incidence of primary-outcome events was 54.4% (95% CI, 48.6 to 59.9) among patients who were enrolled during the intervention phase and 56.2% (95% CI, 54.2 to 58.1) among patients who were enrolled during the control phase (adjusted hazard ratio, 0.95; 95% CI, 0.92 to 0.99). Fewer than six deaths or hospitalizations for any cause occurred in low- or intermediate-risk patients before the first outpatient visit within 30 days after discharge.Among patients with acute heart failure who were seeking emergency care, the use of a hospital-based strategy to support clinical decision making and rapid follow-up led to a lower risk of the composite of death from any cause or hospitalization for cardiovascular causes within 30 days than usual care. (Funded by the Ontario SPOR Support Unit and others; COACH ClinicalTrials.gov number, NCT02674438.).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大熊猫完成签到,获得积分10
刚刚
Lin完成签到 ,获得积分10
刚刚
1秒前
1秒前
快乐滑板应助陶醉的若枫采纳,获得10
1秒前
1秒前
qsh完成签到 ,获得积分10
1秒前
fcyyc完成签到,获得积分10
2秒前
yhengdyheng完成签到,获得积分10
2秒前
传奇3应助独特的翠芙采纳,获得10
3秒前
tangtang完成签到,获得积分10
3秒前
4秒前
5秒前
长风完成签到,获得积分10
5秒前
fcyyc发布了新的文献求助10
6秒前
6秒前
量子星尘发布了新的文献求助10
6秒前
6秒前
杨琳完成签到,获得积分10
6秒前
灵巧的宝马完成签到,获得积分10
7秒前
8秒前
8秒前
8秒前
RGG完成签到,获得积分10
9秒前
9秒前
9秒前
10秒前
奋斗灵珊发布了新的文献求助10
10秒前
量子星尘发布了新的文献求助10
10秒前
11秒前
乐乐应助呼噜采纳,获得10
11秒前
晴朗发布了新的文献求助10
11秒前
12秒前
hanlin完成签到,获得积分10
12秒前
科研通AI6.1应助萝卜采纳,获得10
12秒前
虫虫完成签到 ,获得积分10
12秒前
12秒前
13秒前
木子完成签到 ,获得积分10
13秒前
科研通AI6.1应助w8816采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Agyptische Geschichte der 21.30. Dynastie 3000
„Semitische Wissenschaften“? 1510
从k到英国情人 1500
Cummings Otolaryngology Head and Neck Surgery 8th Edition 800
Real World Research, 5th Edition 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5758723
求助须知:如何正确求助?哪些是违规求助? 5517424
关于积分的说明 15391899
捐赠科研通 4895959
什么是DOI,文献DOI怎么找? 2633441
邀请新用户注册赠送积分活动 1581527
关于科研通互助平台的介绍 1537155